Md Anderson Cancer Center, RNA and COVID-19
Digest more
Techno-Science.net on MSN
💉 More robust messenger RNA for future vaccines
Scientists from CNRS have developed new stable and effective messenger RNA (mRNA) sequences that enable cells to produce therapeutic proteins themselves, capable of inducing antibody
Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted mRNA shots could limit tumor growth by making unresponsive tumors into responsive ones.
Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public offering in Hong Kong, according to people familiar with the matter.